4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-078195
Options or other derivatives
- Director acquired 10,848,678 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Menzel Garry E Director | 2023-07-05 | Grant or award · Option to Purchase Ordinary Shares | +736,548 | 736,548 | D: show line 1 in the form | ||
| Menzel Garry E Director | 2023-07-05 | Grant or award · Option to Purchase Ordinary Shares | +1,251,966 | 1,251,966 | D: show line 2 in the form | ||
| Menzel Garry E Director | 2023-07-05 | Grant or award · Option to Purchase Ordinary Shares | +359,700 | 359,700 | D: show line 3 in the form | ||
| Menzel Garry E Director | 2023-07-05 | Grant or award · Option to Purchase Ordinary Shares | +3,568,026 | 3,568,026 | D: show line 4 in the form | ||
| Menzel Garry E Director | 2023-07-05 | Grant or award · Option to Purchase Ordinary Shares | +57,846 | 57,846 | D: show line 5 in the form | ||
| Menzel Garry E Director | 2023-07-05 | Grant or award · Option to Purchase Ordinary Shares | +2,715,816 | 2,715,816 | D: show line 6 in the form | ||
| Menzel Garry E Director | 2023-07-05 | Grant or award · Option to Purchase Ordinary Shares | +2,158,776 | 2,158,776 | D: show line 7 in the form |
Loading xslF345X04/tm2320409-8_4seq1.xml…